Skip to content
lifestyle.ubi-interactive.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Belite Bio, Inc
Belite Bio to Host Webcast on November 12, 2026, to Discuss Third Quarter 2026 Financial Results
November 5, 2026
Belite Bio Announces Uplisting to the Nasdaq Global Select Market
October 19, 2026
Belite Bio Announces Multi-Market Submission of Marketing Authorization Applications Via the Access Consortium Pathway for Tinlarebant for the Treatment of Stargardt Disease Type 1
October 14, 2026
Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences
October 1, 2026
Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences
September 28, 2026
Belite Bio submits tinlarebant NDA in Japan for Stargardt Disease
September 8, 2026
Belite Bio to Participate in Four Upcoming Investor Conferences
September 1, 2026
Belite Bio to Host Virtual Commercial Day on September 2, 2026
August 24, 2026
Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences
August 21, 2026
Belite Bio Reports Unaudited Second Quarter 2026 Financial Results and Provides a Corporate Update
August 12, 2026
1
2
3
Next Page
→